The recent suspension of Australia's only self-test for gonorrhoea and chlamydia by the TGA has raised concerns about the accuracy of at-home testing methods. This development highlights the importance of reliable diagnostic tools in sexual health, especially as self-testing gains popularity. The TouchBio chlamydia and gonorrhoea self-test, which relies on self-collected vaginal swabs, has been found to produce false negatives, potentially leading to missed diagnoses and untreated infections. The TGA's decision to suspend the device's registration underscores the critical need for thorough verification of diagnostic accuracy, particularly for at-home testing kits. This incident serves as a reminder that while self-testing can be convenient, it must be complemented by robust regulatory oversight to ensure patient safety and effective disease management.
